Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated to v3.6.3, replacing the previous v3.6.0 on the page. This indicates a new site revision without altering study details.SummaryDifference0.0%

- Check16 days agoChange DetectedThe study milestone dates were updated to Primary Completion: 2026-12-31 and Study Completion: 2027-11-30, with the last update posted on 2026-06-18, reflecting a refreshed timeline.SummaryDifference0.2%

- Check30 days agoChange DetectedRecruitment messaging now shows 'No longer looking for participants', the treatment label is standardized to 'Intervention/Treatment' (replacing 'Intervention / Treatment'), several help/navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision badge updates from v3.5.4 to v3.6.0.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision: v3.5.4 was added and the previous revision v3.5.3 was removed, indicating a small metadata update to the page.SummaryDifference0.0%

- Check59 days agoChange DetectedA new bibliographic citation to a 2025 biomarker-driven study on metastatic gastric/GEJ cancer was added to Publications, expanding the referenced literature for the trial page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe study locations are updated to reflect the renamed New Aquitaine region for Pessac and Poitiers, and the page revision is updated to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.